Giuseppe Paolisso

Active 1986–2025

223
Papers
28,614
Citations
102
h-index
214
i10-index

Citations

Citations per year for Giuseppe Paolisso1988: 1 citations1989: 3 citations1990: 2 citations1991: 1 citations1992: 9 citations1993: 6 citations1994: 15 citations1995: 38 citations1996: 39 citations1997: 63 citations1998: 60 citations1999: 103 citations2000: 140 citations2001: 134 citations2002: 199 citations2003: 205 citations2004: 245 citations2005: 255 citations2006: 228 citations2007: 209 citations2008: 235 citations2009: 221 citations2010: 225 citations2011: 164 citations2012: 236 citations2013: 221 citations2014: 209 citations2015: 187 citations2016: 172 citations2017: 172 citations2018: 180 citations2019: 548 citations2020: 744 citations2021: 809 citations2022: 677 citations2023: 474 citations2024: 998 citations2025: 567 citations2026: 9 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,317 citing papers, 20.2% of this breakdownItaly: 1,096 citing papers, 9.5% of this breakdownChina: 1,047 citing papers, 9.1% of this breakdownUnited Kingdom: 804 citing papers, 7% of this breakdownGermany: 438 citing papers, 3.8% of this breakdownCanada: 382 citing papers, 3.3% of this breakdownSpain: 337 citing papers, 2.9% of this breakdownNetherlands: 310 citing papers, 2.7% of this breakdownJapan: 306 citing papers, 2.7% of this breakdownAustralia: 304 citing papers, 2.7% of this breakdownFrance: 293 citing papers, 2.6% of this breakdownIndia: 245 citing papers, 2.1% of this breakdown
0%20.2%Other 31.4%

Fields

  • Medicine67%
  • Biochemistry, Genetics and Molecular Biology19.3%
  • Nursing4.5%
  • Neuroscience3.1%
  • Immunology and Microbiology1.9%
  • Environmental Science0.9%
  • Other3.3%

Topics

  • Diabetes Treatment and Management3.8%
  • Adipokines, Inflammation, and Metabolic Diseases2.7%
  • Adipose Tissue and Metabolism2.4%
  • Nutrition and Health in Aging2.3%
  • Metabolism, Diabetes, and Cancer2%
  • Cardiovascular Function and Risk Factors2%
  • Other84.8%

Coauthors

All papers

Open in search
  1. Microplastics and Nanoplastics in Atheromas and Cardiovascular Events

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Franca Ferraraccio, Iacopo Panarese, Pasquale Paolisso, Emanuele Barbato, Carmine Lubritto, Maria Luisa Balestrieri, Ciro Mauro, A. Enrique Caballero, Sanjay Rajagopalan, Antonio Ceriello, Bruno D’Agostino, Pasquale Iovino, Giuseppe Paolisso - New England Journal of Medicine 2024 cited by 1,002

  2. Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment

    Authors: , , , , , , , - Pharmacological Research 2022 cited by 171

  3. Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes

    Authors: , , , , , , , , , , , , - Pharmacological Research 2022 cited by 137

  4. SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells

    Authors: , , , , , , , , , , , - Theranostics 2023 cited by 90

  5. miR-21 in Human Cardiomyopathies

    Authors: , , , , , - Frontiers in Cardiovascular Medicine 2021 cited by 120

  6. SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis

    Authors: , , , , , , , , , , , , , , - Cardiovascular Diabetology 2023 cited by 106

  7. Gender and telomere length: Systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Changyong Li, Toyoki Maeda, Massimo Mangino, Tim S. Nawrot, Peter M. Nilsson, Katarina Nordfjäll, Giuseppe Paolisso, Fu Ren, Karl Riabowol, Tony Robertson, Göran Roos, Jan A. Staessen, Tim D. Spector, Nelson L.S. Tang, Brad M. Unryn, Pim van der Harst, Jean Woo, Chao Xing, Mohammad E Yadegarfar, Jae Yong Park, Neal S. Young, Diana Kuh, Thomas von Zglinicki, Yoav Ben‐Shlomo - Experimental Gerontology 2013 cited by 519

  8. Tirzepatide prevents neurodegeneration through multiple molecular pathways

    Authors: , , , , , , , , , , , , - Journal of Translational Medicine 2024 cited by 60

  9. Sarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk

    Authors: , , , , , - Life 2021 cited by 144

  10. Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Atherosclerosis 2023 cited by 98

  11. GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes

    Authors: , , , , , , , , , , , , , , , , - Cardiovascular Diabetology 2024 cited by 65

  12. Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database

    Authors: , , , , , , , , - Pharmaceuticals 2024 cited by 52

  13. Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Cachexia Sarcopenia and Muscle 2019 cited by 172

  14. Adiponectin and Cognitive Decline

    Authors: , , - International Journal of Molecular Sciences 2020 cited by 127

  15. SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , - BMC Medicine 2023 cited by 104

  16. Oxidative Stress and Diabetic Vascular Complications

    Authors: , , - Diabetes Care 1996 cited by 1,929

  17. Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts

    Authors: , , , , , , , , , , , , , , , , - Metabolism 2021 cited by 102

  18. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dimitrios Goumenos, Ayşe Tuğba Kartal, Laila‐Yasmin Mani, Hans-Peter Marti, Christopher Mayer, Rikke Nielsen, Vesna Pešić, Merita Rroji, Giorgos K. Sakkas, Goce Spasovski, Kate Stevens, Evgueniy Vazelov, Davide Viggiano, Lefteris C. Zacharia, Ana Carina Ferreira, Jolanta Malyszko, Ewout J. Hoorn, Andreja Figurek, Robert J. Unwin, Carsten A. Wagner, Christoph Wanner, Annette Bruchfeld, Marion Pépin, Andrzej Więcek, Dorothea Nitsch, Ivo Fridolin, Gaye Hafez, María José Soler Romeo, Michelangela Barbieri, Bojan Batinić, Laura Carrasco, Sol Carriazo, Ron T. Gansevoort, Gianvito Martino, Francesco Mattace‐Raso, Ionuţ Nistor, Alberto Ortíz, Giuseppe Paolisso, Daiva Rastenytė, Gabriel Ştefan, Gioacchino Tedeschi, Ziad A. Massy, Boris Bikbov, Karlhans Endlich, Olivier Godefroy, Jean‐Marc Chillon, Anastassia Kossioni, Justina Kurganaite, Norberto Perico, Giuseppe Remuzzi, Tomasz Grodzicki, Francesco Trepiccione, Carmine Zoccali, Mustafa Arıcı, Peter J. Blankestijn, Kai‐Uwe Eckardt, Danilo Fliser, Eugenio Gutiérrez Jiménez, Maximilian König, Ivan Rychlík, Michela Deleidi, György Reusz - Nephrology Dialysis Transplantation 2021 cited by 90

  19. Ergothioneine oxidation in the protection against high-glucose induced endothelial senescence: Involvement of SIRT1 and SIRT6

    Authors: , , , , , , , - Free Radical Biology and Medicine 2016 cited by 129

  20. Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , - Molecular Metabolism 2021 cited by 112

  21. Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists

    Authors: , , , , , , , , , , , - Theranostics 2023 cited by 57

  22. Effects of Nitric Oxide on Cell Proliferation

    Authors: , , , , , , , - Journal of the American College of Cardiology 2013 cited by 283

  23. Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up

    Authors: , , , , , , , , , , , - Frontiers in Pharmacology 2021 cited by 90

  24. Sirtuin 6 Expression and Inflammatory Activity in Diabetic Atherosclerotic Plaques: Effects of Incretin Treatment

    Authors: , , , , , , , , , , , , , , , , - Diabetes 2014 cited by 198